Perovskite Photon Counting X-ray Detectors for Medical Imaging.

Clarity Sensors is developing advanced photon-counting detectors using halide perovskite semiconductors to enhance X-ray imaging resolution while reducing radiation dose, aiming for widespread adoption in clinical settings.

Subsidie
€ 2.494.268
2025

Projectdetails

Introduction

X-ray imaging is a crucial diagnostic tool in modern medicine, with 3.6 billion examinations performed annually. However, X-rays are carcinogenic and pose health risks if not carefully managed. Current detectors used in X-ray imaging and CT scanners prevent advances in image resolution and reduction in radiation dose, limiting screening programs and early disease detection.

Photon-Counting CT Systems

Photon-counting CT (PCCT) systems, which have recently entered the market, offer significant health benefits and present a promising path toward more widespread preventative imaging. However, the adoption of PCCT technology has been slow, primarily due to the energy-intensive and complex fabrication processes of first-generation materials.

Need for Next-Generation Detectors

There is an urgent need for next-generation photon-counting detectors (PCDs) that can:

  • Reduce radiation dose
  • Improve image resolution
  • Streamline manufacturing

Clarity Sensors

Clarity Sensors, a University of Cambridge spin-off, is developing advanced PCDs with halide perovskite semiconductors. Our patented monolithic integration process, combined with leading perovskite quality, positions Clarity Sensors to deliver industry-leading PCDs, targeting the highest image resolution and lowest effective dose, enabling 100 times more scans at the same radiation level.

Project Developments

Through projects such as our ERC Proof-of-Concept (PEROVSCI), we have demonstrated a stable, single-pixel halide perovskite PCD and filed key IP culminating in the fabrication of the first monolithic perovskite PCD on a multi-pixel ASIC.

Future Plans

In PERFORM, we will further develop our technology and business operations to position Clarity Sensors for investment and joint development. This will include:

  1. Optimising our current PCD systems
  2. Developing our working demonstrator, PRISM-X, which will be validated against commercial technologies in clinical settings to reach TRL5
  3. Expanding our technical and commercial team
  4. Securing additional IP
  5. Engaging target customers
  6. Initiating joint-development agreements

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.494.268
Totale projectbegroting€ 2.494.268

Tijdlijn

Startdatum1-6-2025
Einddatum31-5-2028
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • CLARITY SENSORS LIMITEDpenvoerder

Land(en)

United Kingdom

Vergelijkbare projecten binnen EIC Transition

EIC Transition

Low-power consumption, heavy-metal-free wide-spectrum image sensors for mass-market computer vision applications

QSTACK aims to develop a power-efficient, heavy-metal-free wide-spectrum image sensor technology to enhance computer vision applications, boosting the European semiconductor industry's competitiveness.

€ 2.370.937
EIC Transition

Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer

PHIRE aims to develop a novel theranostic device for high-resolution imaging and treatment of bladder cancer lesions under 1 mm, improving patient outcomes and reducing tumor relapse.

€ 2.084.871
EIC Transition

Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid Tumours

ScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027.

€ 2.499.911

Vergelijkbare projecten uit andere regelingen

ERC Starting...

Toward next-generation X-ray imaging: Pb-free PErovskite Charge Transport engineering

X-PECT aims to develop sustainable, lead-free metal halide perovskite X-ray detectors with enhanced sensitivity and stability to reduce radiation exposure in medical and security applications.

€ 2.035.525
ERC Advanced...

3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.

This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields.

€ 3.351.875
ERC Proof of...

Cherenkov light for total-body Positron Emission Tomography

The project aims to develop a cost-effective, high-performance PET scanner using Cherenkov photon detection to enhance early cancer diagnosis and treatment monitoring.

€ 150.000
EIC Pathfinder

NEW TECHNOLOGY FOR 1 MICRON RESOLUTION BIOMEDICAL IMAGING

The 1MICRON project aims to revolutionize cancer detection by developing high-resolution, integrated x-ray sensors for immediate surgical feedback, potentially saving over 100,000 treatments annually in Europe.

€ 2.999.999
EIC Pathfinder

Next generation Limited-Angle time-of-flight PET imager

The PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings.

€ 3.374.041